JUNE 2004

"ISPOR e-BULLETIN" provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to www.ispor.org.

Please pass these updates along to your colleagues.

eBulletin Index

NEW THIS MONTH

**NEW** ISPOR Board of Directors Election Results

**NEW** 9^th Annual International Meeting Contributed Paper Award Recipients

**NEW** 9^th Annual International Meeting Photo Gallery

**NEW** Risk Management SIG Reorganized into Four Areas

**NEW** Clinical Practice SIG Reorganized Around Theme: Dataset to Bedside

ISPOR ONGOING ACTIVITIES

1. Publications

2. Meetings and Congresses

3. Educational Activities

4. Student News

5. ISPOR Special Interest Groups

6. Committee and Task Force Activities

7. Hot Topics

8. Important Dates to Remember

9. Employment in Pharmacoeconomics and Outcomes Research

10. Membership

PUBLICATIONS

Top

VALUE IN HEALTH

Value in Health: Volume 7, Issue 3, May/June 2004 9^th Annual Meeting Contributed Paper Abstracts is online and available this month at: http://www.ispor.org/valueinhealth_index.asp.

HEALTH CARE COST, QUALITY, AND OUTCOMES: ISPOR BOOK OF TERMS

This ISPOR publication includes more than 100 detailed monographs covering over 400 terms used in health care delivery, management, and regulation, as well as health care outcomes research including clinical, economic, and quality-of-life research terms. ISPOR member discounted price is $36.00; a 40% discount! Student/Library/Academic discounted price: $33.00 (a 45% discount). On-line ordering is now available at: http://www.ispor.org/publications/lexicon_index.asp. Contact Stephen Priori at spriori@ispor.org for information on orders over 1000.

ISPOR MEETINGS AND CONGRESSES

Top

7TH ANNUAL EUROPEAN CONGRESS

24-26 October 2004, CCH Congress Centrum Hamburg, Hamburg, Germany

CALL FOR ABSTRACTS AVAILABLE ONLINE

http://www.ispor.org/congresses/germany1004/abstract_instructions.asp

SUBMIT YOUR ABSTRACT NOW!

Abstract Deadline: 21 June 2004

Early Registration Deadline: 28 September 2004

MEETING AT A GLANCE

http://www.ispor.org/congresses/germany1004/index.asp

https://www.ispor.org/forms/contractgermany1004.htm

Sponsorship Opportunities still available, for more information go to

http://www.ispor.org/congresses/germany1004/sponsor.asp

9^TH ANNUAL INTERNATIONAL MEETING

May 16-19, 2004, Crystal Gateway Marriott, Arlington, VA, USA

**NEW** Photo Gallery

http://www.ispor.org/meetings/va0504/autositepg/default.asp

EDUCATION ACTIVITIES

Top

SHORT COURSES- ISPOR 7^TH ANNUAL EUROPEAN CONGRESS

13 ISPOR SHORT COURSES prior to the ISPOR 7^th Annual European Congress 23-24 October NOW available at:http://www.ispor.org/congresses/germany1004/index.asp

STUDENT NEWS

Top

NEW ISPOR STUDENT NETWORK CHAIR

Larry Humble, RPh, Graduate Student, The University of Louisiana at Monroe, Monroe, LA USA, is the newly elected chair for the Student Network for 2004-2005.

ISPOR SPECIAL INTEREST GROUPS (SIG)

Top

Summary of Activities at the 9^th Annual Meeting:

CLINICAL PRACTICE SIG

**NEW** Reorganized around theme: Dataset to Bedside

Projects in development for the year:

Education Working Group:

A one-hour scripted slide show for clinicians on the basics of pharmacoeconomics and application of outcomes research.

Review and Planning for 10^th Annual International Meeting Working Group

A �clinical track' contributed issue panel / workshop / presentation at Annual Meeting Topic: translation of research into clinical recommendations.

Standardized Reporting Working Group

Develop a standardized reporting format for outcomes research or economic evaluations designed for clinicians' use.

For more details, please visit: http://www.ispor.org/sigs/cp.asp

RISK MANAGEMENT SIG

**NEW** Reorganized into four topics:

� Communication Working Group
Co-Chairs: Ateeq Rahman PhD, MBA & Paul Stang PhD

� Identification of Risk Working Group
Co-chair: Nicholas Lipskiy PhD, MBA & Larry Liu MD, PhD

� Interventions/Implementation Working Group

Co-Chair: Anthony Lockett MBA, MD, PhD & Paul Stang, PhD

� Legal and Regulatory Implications Working Group
Chair: TBD
please email emolsen@ispor.org if you are interested in this position.

For more details, please visit: http://www.ispor.org/sigs/rm.asp

MEDICATION COMPLIANCE SIG
Contributed Workshops presented at the 9^th Annual International Meeting:

W2: Patient Compliance and Persistence with Prescribed Medication: Measurement and Health Economic Impact

W10: Methods In Compliance Evaluation: Determining and Analyzing Appropriate Measures

W18: Medication Compliance (Adherence): Issues and Definitions Consensus Workshop

W26: Education Issues in Medication Adherence

QUALITY OF LIFE SIG
Contributed Workshops presented at the 9^th Annual International Meeting:

W6: Advances in Mapping Health-Related Quality of Life: An Eq-5d Index Based on Sf-36 Data

W7: Applying Item Response Theory Modeling for Improving Health Outcomes Measurement

W23: Challenges in Developing Outcome Instruments to Show the Value of New Therapies in Sever Mental Illness

PATIENT REGISTRY SIG

Convened an open meeting of all interested members.

* Fun Fact / Statistic: 612 ISPOR members have joined a SIG

Special Interest Group membership is open to ALL ISPOR members.

To JOIN any SIG: http://www.ispor.org/sigs/joinsig.asp

ISPOR COMMITTEE AND TASK FORCE ACTIVITIES

Top

**NEW** ISPOR Board of Directors Election Results

The new elected members of the ISPOR Board of Directors will take office on July 1, 2004.� They are:

2004-2005 President-elect and 2005-2006 President

Peter J. Neumann, ScD, Associate Professor of Policy and Decision Sciences, Harvard School of Public Health, Boston, MA, USA

2004-2006 Directors

Isao Kamae MD, DrPH, Professor of Biostatistics and Health Decision Sciences, Kobe University, Kobe, Japan

Capt. Laurie Beth Burke, RPh, MPH, Director, Study Endpoints and Label Development, Office of New Drugs, CDER, FDA, Rockville, MD, USA

Jens Grueger PhD, Head of Pricing and Health Economics, Novartis Pharmaceuticals, Basil, Switzerland

These board members will join the incumbent Board members:

2004-2005 President

Lieven Annemans PhD, Director, HEDM, Meise, Belgium

2004-2005 Past President

Past-President Sean D. Sullivan, PhD, Professor, University of Washington
Seattle, WA, USA

2003-2005 Directors

Randel E. Richner BSN, MPH, Vice President, Federal Affairs, Reimbursement and Outcomes Planning, Boston Scientific Corporation, Boston, MA, USA

Marcus D. Wilson PharmD, President, Chief Executive Officer,
Health Core, Inc., Wilmington, DE, USA

AWARD COMMITTEE ACTIVITIES

**NEW** ISPOR NINTH ANNUAL INTERNATIONAL MEETING CONTRIBUTED PAPER AWARDS RECIPIENTS

BEST CONTRIBUTED PAPER AWARDS PODIUM PRESENTATIONS

GENERAL

HM4
HOW ROBUST IS COST-EFFECTIVENESS RATIO TO MISSING DATA IMPUTATION? ANALYSIS OF LONG-TERM CLINICAL TRIAL IN PARKINSONS DISEASE
Noyes K, Holloway RG, Dick AW
University of Rochester School of Medicine, Rochester, NY, USA �

PE1
ASSESSING EFFECTIVENESS IN THE PRESENCE OF TREATMENT SWITCHING: DATA FROM AN EFFECTIVENESS STUDY OF ANTIPSYCHOTICS
Faries D¹, Nyhuis A¹, Tunis SL¹, Hernan M²
¹Eli Lilly and Company, Indianapolis, IN, USA; ²Harvard School of Public Health, Boston, MA, USA

RI3
COST-EFFECTIVENESS OF INFLUENZA VACCINE IN 6-24 MONTH OLD CHILDREN
Woolcott JC¹, Marra F¹, Brunham RC²
¹BC Centre for Disease Control, Vancouver, BC, Canada; ²University of British Columbia Centre for Disease Control, Vancouver, BC, Canada �

NEW INVESTIGATOR

CV1
HEALTH PREFERENCES AFTER CABG OR PCI FOLLOWING AN ACUTE MYOCARDIAL INFARCTION
Radeva J, Reed S, Weinfurt K, Anstrom K, Velazquez E, Schulman K
Duke Clinical Research Institute, Durham, NC, USA �

HP1
EVALUATION OF GENERIC DISPENSING INCENTIVE PROGRAM (GDIP)
Hong SH

University of Arkansas for Medical Sciences, Little Rock, AR, USA �

MH4
ASSESSMENT OF HEALTH STATE UTILITIES FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN CHILDREN USING PARENT-BASED STANDARD GAMBLE SCORES
Secnik K¹, Cottrell S², Matza L³, Edgell E⁴, Aristides M⁵, Tilden D², Burridge J⁵, Mannix S⁶
¹Eli Lilly and Company, Indianapolis, IN, USA; ²M-TAG Pty Ltd., London, England; ³MEDTAP International, Bethesda, MD, USA; ⁴Lilly Research Centre, Windlesham, United Kingdom; ⁵M-TAG Limited, London, United Kingdom; ⁶MEDTAP International, Inc, Bethesda, MD, USA

STUDENT

AC3
COMPARISION OF ADHERENCE TO ANTIHYPERTENSIVES IN A MANAGED CARE POPULATION
Naik RK¹, Borrego ME¹, Gupchup GV¹, D'Angio R², Sabrsula S³
¹University of New Mexico, Albuquerque, NM, USA; ²Pfizer Inc, Albuquerque, NM, USA; ³Firstcare MCO, Albuquerque, NM, USA

OP2
COMPARISON OF DISCRETE CHOICE EXPERIMENT (DCE) WITH VISUAL ANALOG SCALING (VAS) METHODS FOR ESTIMATING PREFERENCES FOR PHYSICAL DISABILITY STATES
Banks JL¹, Netten A², Ryan M³, Watson V⁴, Salas M⁵
¹University of Kent at Canterbury, Lincoln, MA, USA; ²University of Kent at Canterbury, Canterbury, Kent, United Kingdom; ³University of Aberdeen, Aberdeen, United Kingdom; ⁴University of Aberdeen Medical School, Aberdeen, United Kingdom; ⁵Erasmus University Medical School, Rotterdam, Netherlands

SC4E
ECONOMIC EVALUATION OF SCREENING FOR THE A-ADDUCIN GENE VARIANT IN HYPERTENSIVE PATIENTS
Meckley LM, Veenstra DL
University of Washington, Seattle, WA, USA

BEST CONTRIBUTED PAPER AWARDS POSTER PRESENTATIONS

GENERAL

PAR18
RACIAL DISPARITIES IN PRESCRIBING OF SELECTIVE CYCLOOXYGENASE-2 INHIBITORS OVER OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS IN A MEDICAID MANAGED CARE POPULATION
Shaya FT, Blume SW, Blanchette CM, Mullins CD
University of Maryland, Baltimore, MD, USA

PCV47
THE NATIONAL ANTICOAGULATION BENCHMARK AND OUTCOMES REPORT (NABOR�): EVIDENCE OF A SIGNIFICANT DIFFERENCE BETWEEN GUIDELINES AND ACTUAL PRACTICE
Shillington A¹, Tapson V², Hyers T³, Becker R², Colgan K¹
¹EPI-Q, Inc, Oakbrook Terrace, IL, USA; ²Duke University Medical Center, Durham, NC, USA; ³CARE Clinical Research, St. Louis, MO, USA

PHP34
EXPLICIT INDICATORS TO MEASURE PREVENTABLE DRUG-RELATED MORBIDITY IN AN ELDERLY POPULATION
Faris RJ
University of Tennessee, Memphis, TN, USA

NEW INVESTIGATOR

PCV42
PERSISTENCE AND ADHERENCE TO STATIN THERAPY IN A MANAGED CARE SETTING
Quach C¹, Nichol MB², Chen L¹, Patel BV¹, Berenbeim D¹
¹MedImpact Health Care Systems Inc, San Diego, CA, USA; ²University of Southern California, Los Angeles, CA, USA

PCV51
RETROSPECTIVE EVALUATION OF UTILIZATION PATTERNS OF BETA-BLOCKER THERAPY IN CONGESTIVE HEART FAILURE PATIENTS IN A MANAGED CARE ENVIRONMENT
Thaker DJ, Godley PJ, Browne BA, Rohack J, Houck P
Scott & White, Temple, TX, USA

PIN1
OUTCOMES OF AN INTERACTIVE VOICE RESPONSE (IVR) REMINDER SYSTEM TO PROMOTE MANAGED CARE ORGANIZATION (MCO) MEMBERS' ATTAINMENT OF INFLUENZA IMMUNIZATION
Sikirica V¹, Crawford A¹, Goldfarb N¹, Nash D¹, Popiel R², Patel M², Wang C², Chu J²
¹Department of Health Policy, Jefferson Medical College, Philadelphia, PA, USA; ²Horizon Blue Cross Blue Shield of New Jersey, Newark, NJ, USA

STUDENT

PAR7
ASSESSMENT OF PATIENT-REPORTED OUTCOMES AMONG OSTEOARTHRITIC PATIENTS
Gandra SR, Lawrence LW
The University of Louisiana at Monroe, Monroe, LA, USA

PCN20
PRELIMINARY ECONOMIC ANALYSIS OF THE AMERICAN CANCER SOCIETY GUIDELINES FOR MAMMOGRAPHY SCREENING IN AVERAGE-RISK WOMEN UNDER 70 YEARS OF AGE
Zammit D, Hay J
University of Southern California, Los Angeles, CA, USA

PMD15
RELIABILITY AND VALIDITY OF THE EQ-5D SELF-REPORT QUESTIONNAIRE IN TAIWAN POPULATION
Chang TJ, Tarn YH
National Defense Medical Center, Taipei, Taiwan

2004 ISPOR SCIENTIFIC AWARDEES: http://www.ispor.org/awards/index_.asp

2004 ISPOR SERVICE AWARDEES: http://www.ispor.org/awards/service/service.asp

distinguish.asp

RANDOMIZED CLINICAL TRIALS ALONGSIDE COST EFFECTIVENESS ANALYSIS (RCT-CEA) TASK FORCE

Randomized Clinical Trials Alongside Cost Effectiveness Analysis (RCT-CEA) held it's first public forum at the ISPOR 9^th Annual International Meeting in Arlington, Virginia, May 17, 2004.� To view this presentation, go to http://www.ispor.org/workpaper/clinical_trial.asp �

The next presentation of this task force will be held at the 7^th Annual European Congress to be held October 24-26, 2004 in Hamburg, Germany.

HOT TOPICS

Top

SENATOR TO UNVEIL DRUG IMPORTATION BILL THIS WEEK

WASHINGTON (Reuters) - Recognizing voter concern about the high cost of medicines, a key U.S. Senate committee chairman said Tuesday he plans to unveil this week legislation that would allow importation of cheaper drugs from Canada and other countries.

For full text of the article, go to: http:// story.news.yahoo.com/news?tmpl=story&cid=594&ncid=594&e=3&u=/nm/20040601/hl_nm/congress_drugs_dc

IMPORTANT DATES TO REMEMBER

Top

June 21, 2004 � Deadline to submit abstracts for the 7^th Annual European Congress.� For submission guidelines go to: http://www.ispor.org/congresses/germany1004/abstract_instructions.asp.

September 28, 2004 � Early registration deadline for the 7^th Annual European Congress.� For register, go to: http://www.ispor.org/members/events/closed.asp

October 24-26, 2004 � ISPOR 7^th Annual European Congress, CCH Congress Centrum Hamburg, Hamburg, Germany.

EMPLOYMENT

Top

9 New positions posted at the ISPOR Website since the last e-bulletin

http://www.ispor.org/employment/employment_index.asp

Advertise your positions on ISPOR Web (up to 1 million hits per month)

PRAP, Professional Recruitment Center:

At the ISPOR 9^th Annual International Meeting, the ISPOR PRAP Center was a great success. With over 33 positions and 65 candidates, the center was constantly in motion.

For information on PRAP at the 7^th Annual European Congress, go to: http://www.ispor.org/prap.asp

ISPOR MEMBERSHIP

Top

Update your email address at https://www.ispor.org/members/addresschange.asp! Your email address is required as part of your log in information in the members only section of the ISPOR website.